Benitec Biopharma Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jerel A. Banks, with a market cap of $378.2M.
Common questions about Benitec Biopharma Inc.
Benitec Biopharma Inc. is scheduled to report earnings for Q3 2026 on May 13, 2026.
Benitec Biopharma Inc. has approximately 16 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.